A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cryptenamine
R,S-Warfarin alcohol
The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Desipramine.
Cryptenamine
(R)-warfarin
The serum concentration of (R)-warfarin can be increased when it is combined with Desipramine.
Cryptenamine
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Desipramine.
Cryptenamine
Glycopyrronium
The risk or severity of adverse effects can be increased when Desipramine is combined with Glycopyrronium.
Cryptenamine
Yohimbine
The serum concentration of Yohimbine can be increased when it is combined with Desipramine.
Cryptenamine
Lithium citrate
Lithium citrate may increase the neurotoxic activities of Desipramine.
Cryptenamine
Lithium hydroxide
Lithium hydroxide may increase the neurotoxic activities of Desipramine.
Cryptenamine
Dexmethylphenidate
The serum concentration of Desipramine can be increased when it is combined with Dexmethylphenidate.
Cryptenamine
Betahistine
The therapeutic efficacy of Betahistine can be decreased when used in combination with Desipramine.
Cryptenamine
Benzylpenicilloyl polylysine
Desipramine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
Cryptenamine
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Desipramine.
Cryptenamine
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Desipramine.
Cryptenamine
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Desipramine.
Cryptenamine
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Desipramine.
Cryptenamine
Colchicine
The metabolism of Colchicine can be decreased when combined with Desipramine.
Cryptenamine
Cilostazol
The metabolism of Cilostazol can be decreased when combined with Desipramine.
Cryptenamine
Naxitamab
The risk or severity of hypertension can be increased when Desipramine is combined with Naxitamab.
Cryptenamine
Selpercatinib
The risk or severity of hypertension can be increased when Desipramine is combined with Selpercatinib.
Cryptenamine
Moxisylyte
The risk or severity of hypertension can be increased when Desipramine is combined with Moxisylyte.
Cryptenamine
Terguride
The risk or severity of hypertension can be increased when Desipramine is combined with Terguride.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3